Hanmi Pharm. Co. on Friday reported its second-quarter net profit of 20.8 billion won (US$16.3 million), down 8.1 percent from a year earlier.
The company said in a regulatory filing that it posted 33.2 billion won in operating profit for the quarter, compared with 31.6 billion won a year ago. Sales rose 8.1 percent to 342.7 billion won.
The earnings exceeded market expectations. The average estimate of net profit by analysts stood at 18.5 billion won, according to a survey by Yonhap Infomax, the financial data firm of Yonhap News Agency.
Source: Yonhap News Agency